From: Efficacy and safety of intravitreal injections of conbercept for the treatment of idiopathic choroidal neovascularization
Characteristics
Patients, n = 40 (eyes, n = 40)
Sex (eye)
Male
20
Female
Age (years)
30.93 ± 4.99
Time from symptom onset to start of treatment (days)
7.78 ± 3.79
Type (eye)
Subfoveal
40
IOP (mmHg)
15.45 ± 2.71